NCT00460460View on ClinicalTrials.gov

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

PHASE1TerminatedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

August 31, 2007

Conditions

Lymphoma

Interventions

DRUG

AZD4877

Trial Locations (3)

Unknown

Research site, Buffalo

Research Site, New York

Research Site, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY